Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis (Q26827599)

language of work or name

1 reference

May 2014

1 reference

Alimentary Pharmacology & Therapeutics

published in

1 reference

volume

39

1 reference

issue

10

1 reference

page(s)

1043-58

1 reference

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

cites work

1 reference

Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy

21 January 2018

1 reference

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

21 January 2018

1 reference

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis

21 January 2018

1 reference

Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.

21 January 2018

1 reference

Favorable outcomes of autoimmune hepatitis in a community clinic setting

21 January 2018

1 reference

Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center

21 January 2018

1 reference

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

21 January 2018

1 reference

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

21 January 2018

1 reference

Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis

21 January 2018

1 reference

Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

21 January 2018

1 reference

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis

21 January 2018

1 reference

Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.

21 January 2018

1 reference

Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II.

21 January 2018

1 reference

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

Aetiopathogenesis of autoimmune hepatitis

21 January 2018

1 reference

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

21 January 2018

1 reference

Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy

21 January 2018

1 reference

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission

21 January 2018

1 reference

Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand

21 January 2018

1 reference

Hepatocellular carcinoma and other malignancies in autoimmune hepatitis

21 January 2018

1 reference

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study

21 January 2018

1 reference

Early pregnancy azathioprine use and pregnancy outcomes

21 January 2018

1 reference

Use of thiopurines in inflammatory bowel disease

21 January 2018

1 reference

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan.

21 January 2018

1 reference

Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis

21 January 2018

1 reference

Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis

21 January 2018

1 reference

Aetiopathogenesis of autoimmune hepatitis

21 January 2018

1 reference

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

21 January 2018

1 reference

Induction, acceleration or prevention of autoimmunity by molecular mimicry

21 January 2018

1 reference

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

21 January 2018

1 reference

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.

21 January 2018

1 reference

Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?

21 January 2018

1 reference

Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

21 January 2018

1 reference

CXCL10 and autoimmune diseases

21 January 2018

1 reference

Mucosal immunity in liver autoimmunity: a comprehensive review

21 January 2018

1 reference

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

21 January 2018

1 reference

Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly

21 January 2018

1 reference

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

Autoimmune hepatitis following hepatitis A virus infection

21 January 2018

1 reference

Autoimmune hepatitis triggered by acute hepatitis A

21 January 2018

1 reference

Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance

21 January 2018

1 reference

Persistent measles virus genome in autoimmune chronic active hepatitis

21 January 2018

1 reference

Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly

21 January 2018

1 reference

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody

21 January 2018

1 reference

Seasonal variation in the patient diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology

21 January 2018

1 reference

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

21 January 2018

1 reference

Drug-Induced Autoimmune-Like Hepatitis

21 January 2018

1 reference

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland

21 January 2018

1 reference

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

21 January 2018

1 reference

Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.

21 January 2018

1 reference

Autoantigens in systemic autoimmunity: critical partner in pathogenesis

21 January 2018

1 reference

Caspase-dependent cleavage of nucleic acids

21 January 2018

1 reference

Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus

21 January 2018

1 reference

Apoptosis-associated antigens recognized by autoantibodies in patients with the autoimmune liver disease primary biliary cirrhosis.

21 January 2018

1 reference

Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease

21 January 2018

1 reference

Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus

21 January 2018

1 reference

Lifespans of naive, memory and effector lymphocytes

21 January 2018

1 reference

In vivo estimates of division and death rates of human T lymphocytes

21 January 2018

1 reference

Lifespan of human memory T-cells in the absence of T-cell receptor expression

21 January 2018

1 reference

B-cell memory is short-lived in the absence of antigen.

21 January 2018

1 reference

Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs.

21 January 2018

1 reference

CD4 memory T cells on trial: immunological memory without a memory T cell

21 January 2018

1 reference

Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.

21 January 2018

1 reference

Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance

21 January 2018

1 reference

Chemokine-directed immune cell infiltration in acute and chronic liver disease

21 January 2018

1 reference

CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid

21 January 2018

1 reference

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

21 January 2018

1 reference

TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression

21 January 2018

1 reference

Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.

21 January 2018

1 reference

Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation

21 January 2018

1 reference

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

Genetic bases of autoimmune hepatitis.

21 January 2018

1 reference

Rapidity of treatment response and outcome in type 1 autoimmune hepatitis

21 January 2018

1 reference

Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans

21 January 2018

1 reference

Hypothesis: The Aging Paradox and Autoimmune Disease

21 January 2018

1 reference

Immune senescence: mechanisms and clinical implications

21 January 2018

1 reference

Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly

21 January 2018

1 reference

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease

21 January 2018

1 reference

Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese

21 January 2018

1 reference

Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

21 January 2018

1 reference

The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-beta1.

21 January 2018

1 reference

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link

21 January 2018

1 reference

C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis.

21 January 2018

1 reference

Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

21 January 2018

1 reference

Chemokines in the systemic organization of immunity

21 January 2018

1 reference

Long-term follow-up of chronic active hepatitis of moderate severity

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

Early Predictors of Corticosteroid Treatment Failure in Icteric Presentations of Autoimmune Hepatitis Δ

21 January 2018

1 reference

Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

21 January 2018

1 reference

Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy

21 January 2018

1 reference

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

21 January 2018

1 reference

Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis

21 January 2018

1 reference

Use of TNFα antagonists in refractory AIH: revealing the unforeseen

21 January 2018

1 reference

Advances in the current treatment of autoimmune hepatitis

21 January 2018

1 reference

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

21 January 2018

1 reference

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

21 January 2018

1 reference

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

21 January 2018

1 reference

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor α polymorphisms at position −308

21 January 2018

1 reference

In utero exposure to mycophenolate mofetil: A characteristic phenotype?

21 January 2018

1 reference

7 January 2021

Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule

1 reference

7 January 2021

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

7 January 2021

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

7 January 2021

Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

7 January 2021

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

7 January 2021

CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice

1 reference

7 January 2021

Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

1 reference

7 January 2021

Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease

1 reference

7 January 2021

Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance

1 reference

7 January 2021

Recurrent autoimmune hepatitis after liver transplantation: a disease continuum or a fresh start?

1 reference

7 January 2021

Autoimmune chronic active hepatitis developing after acute type B hepatitis

1 reference

7 January 2021

Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal

1 reference

7 January 2021

Reply: To PMID 23090425

1 reference

7 January 2021

Azathioprine (Imuran) and pregnancy

1 reference

7 January 2021

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

7 January 2021

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

7 January 2021

1 reference

7 January 2021

Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype

1 reference

7 January 2021

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

7 January 2021

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

7 January 2021

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

7 January 2021

Duration of immunosuppressive therapy in autoimmune hepatitis

1 reference

7 January 2021

Pathogenesis of autoimmune hepatitis

1 reference

7 January 2021

Prenatal exposure to mycophenolate mofetil: an updated estimate.

1 reference

7 January 2021

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

7 January 2021

Chemokines in Liver Inflammation and Fibrosis

1 reference

7 January 2021

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

1 reference

7 January 2021

Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis

1 reference

7 January 2021

Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients

1 reference

7 January 2021

Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival

1 reference

7 January 2021

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

1 reference

7 January 2021

A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis

1 reference

7 January 2021

Consequences of treatment withdrawal in type 1 autoimmune hepatitis

1 reference

7 January 2021

Features and consequences of untreated type 1 autoimmune hepatitis

1 reference

7 January 2021

Hepatitis B re-activation with rituximab therapy: treat the patient not the disease

1 reference

7 January 2021

Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse

1 reference

7 January 2021

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases

1 reference

7 January 2021

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

1 reference

7 January 2021

Safety issues in the management of autoimmune hepatitis

1 reference

7 January 2021

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver

1 reference

7 January 2021

Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1111/APT.12701

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24628539

1 reference

Consolidated OpenCitations Corpus – April 2017